Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,720 | 41,793 | 47,871 | 90,255 | 137,035 |
| TOTAL | $11,092 | $43,791 | $50,715 | $90,789 | $138,273 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 369 | 621 |
| Other Non-Current Assets | 0 | 1,526 | 1,096 | 3,189 | 3,938 |
| TOTAL | $N/A | $1,526 | $1,096 | $3,558 | $4,559 |
| Total Assets | $11,092 | $45,317 | $51,811 | $94,347 | $142,832 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 329 | 868 | 970 | 2,108 | 2,090 |
| Accrued Expenses | 5,382 | 5,226 | 6,992 | 8,715 | 9,440 |
| TOTAL | $5,778 | $6,835 | $8,881 | $11,824 | $12,428 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 67 | 0 | 919 | 2,184 |
| TOTAL | $N/A | $67 | $N/A | $919 | $2,184 |
| Total Liabilities | $5,778 | $6,902 | $8,881 | $12,743 | $14,613 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 645 | 645 | 642 | 523 | 515 |
| Common Shares | 65 | 64 | 54 | 52 | 49 |
| Retained earnings | -494,364 | -456,485 | -419,586 | -372,897 | -309,470 |
| TOTAL | $5,314 | $38,414 | $42,930 | $81,604 | $128,220 |
| Total Liabilities And Equity | $11,092 | $45,317 | $51,811 | $94,347 | $142,832 |